Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index; 72 of the 108 sources its claims cite were checked for support.

Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics

Open access
Adejuyigbe, Babapelumi, Kallini, Julie, Chiou, Daniel, Kallini, Jennifer R. · 2023 · International Journal of Molecular Sciences

Abstract

Osteoporosis is a major public health concern affecting millions of people worldwide and resulting in significant economic costs. The condition is characterized by changes in bone homeostasis, which lead to reduced bone mass, impaired bone quality, and an increased risk of fractures. The pathophysiology of osteoporosis is complex and multifactorial, involving imbalances in hormones, cytokines, and growth factors. Understanding the cellular and molecular mechanisms underlying osteoporosis is essential for appropriate diagnosis and management of the condition. This paper provides a comprehensive review of the normal cellular and molecular mechanisms of bone homeostasis, followed by an in-depth discussion of the proposed pathophysiology of osteoporosis through the osteoimmunological, gut microbiome, and cellular senescence models. Furthermore, the diagnostic tools used to assess osteoporosis, including bone mineral density measurements, biochemical markers of bone turnover, and diagnostic imaging modalities, are also discussed. Finally, both the current pharmacological and non-pharmacological treatment algorithms and management options for osteoporosis, including an exploration of the management of osteoporotic fragility fractures, are highlighted. This review reveals the need for further research to fully elucidate the molecular mechanisms underlying the condition and to develop more effective therapeutic strategies.

Overview

CoChat Summary

TL;DR

This narrative review synthesizes normal bone homeostasis and proposed osteoimmunological, gut microbiome, and cellular senescence models of osteoporosis, alongside current diagnostic and treatment approaches. It emphasizes DEXA-based BMD diagnosis, bone turnover markers, and pharmacologic/non-pharmacologic management, while calling for further research into molecular mechanisms and better therapies.

Key findings

  • Osteoporosis affects over 14 million people in the US and over 200 million globally; one in three women and one in five men aged 50 or over are estimated to suffer osteoporosis-related fragility fractures. The annual economic burden is USD 6.5 trillion across the US, Canada, and Europe, with the US burden projected to reach USD 25.3 billion by 2025.
  • The review frames osteoporosis as a multifactorial bone-remodeling imbalance, extending the traditional endocrine model (estrogen deficiency, secondary hyperparathyroidism, vitamin D/calcium imbalance) with osteoimmunological, gut microbiome, and cellular senescence models. Genetic findings include BMD variance up to 80% in twin studies, up to 144 genes linked to BMD variance, and rs11692564 showing a +0.20 SD effect on lumbar spine BMD.
  • Diagnosis primarily relies on DEXA BMD: WHO categories are normal > −1 SD t-score, osteopenia between −1 and −2.5 SD, osteoporosis < −2.5 SD, and established osteoporosis < −2.5 SD plus fragility fracture; sensitivity and specificity are close to 90%. Bone turnover markers and FRAX are also discussed, as is novel CT Hounsfield unit screening.
  • Treatment findings include calcium and vitamin D supplementation reducing hip fracture risk by 30% and total fracture risk by 12–15%; denosumab in FREEDOM reduced vertebral fractures by 68%, hip fractures by 40%, and non-vertebral fractures by 20% over the first three years; romosozumab in FRAME reduced new vertebral fractures by 73% versus placebo, and ARCH showed a 48% lower risk of new vertebral fractures versus alendronate-only. Prolonged bisphosphonate use (5+ years) is associated with atypical femur fractures, which affect the contralateral leg in 28% of cases.

Methods

  • Design: comprehensive narrative review; no primary data collection or systematic review methodology is stated.
  • Data/sample: literature on bone homeostasis, osteoporosis pathophysiology, diagnostics, and therapeutics, including human studies and animal models such as rats and mice.
  • Analysis: thematic synthesis of cellular and molecular mechanisms, proposed pathophysiologic models, diagnostic tools, and treatment algorithms; no meta-analysis or formal quality appraisal is described.

Limitations

  • Stated: the paper concludes that further research is needed to fully elucidate the molecular mechanisms underlying osteoporosis and to develop more effective therapeutic strategies.
  • Evident from the text: as a narrative review, it does not report a systematic search strategy, inclusion/exclusion criteria, or risk-of-bias assessment, and its conclusions rely on cited literature rather than new primary data.
  • Evident from the text: several pathophysiologic insights derive from animal models (e.g., rat, mouse, germ-free mice), which may not fully translate to human osteoporosis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms241914583

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 A side-by-side illustration depicting the stark contrast between normal and osteoporotic bone. The normal bone structure (right) is well defined, demonstrates a thick trabecular architecture within the bone matrix, demonstrates sufficient mineralization and calcium content, and, finally, shows minimal signs of fractures of degradation. The osteoporotic bone (left) shows signs of advanced bone loss and weakening. There is a dramatic reduction in trabecular density and thickness, resulting in a porous and fragile appearance. The pronounced gaps and voids within the bone matrix represent areas of compromised strength.
Figure 1 A side-by-side illustration depicting the stark contrast between normal and osteoporotic bone. The normal bone structure (right) is well defined, demonstrates a thick trabecular architecture within the bone matrix, demonstrates sufficient mineralization and calcium content, and, finally, shows minimal signs of fractures of degradation. The osteoporotic bone (left) shows signs of advanced bone loss and weakening. There is a dramatic reduction in trabecular density and thickness, resulting in a porous and fragile appearance. The pronounced gaps and voids within the bone matrix represent areas of compromised strength.CC BY · PubMed Central

Verification

Claims the paper makes

49 Valid · 7 Not valid · 16 Not checked · 3 Own results and interpretations

35 more claims · 28 with their cited sources checked

Create a free account to see all 75 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 99 references

Research works printed but not linked: 6

  1. Feingold, K.R., Anawalt, B., Boyce, A., Blackman, M.R., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hofland, J. (2023, January 09). The Epidemiology and Pathogenesis of Osteoporosis, Endotext, Available online: http://www.ncbi.nlm.nih.gov/books/NBK279134/.
  2. Burr, D.B., and Allen, M.R. (2014). Basic and Applied Bone Biology, Academic Press.
  3. Rowe, P., Koller, A., and Sharma, S. (2023, January 15). Physiology, Bone Remodeling, Available online: http://www.ncbi.nlm.nih.gov/books/NBK499863/.
  4. Keen, M.U., and Reddivari, A.K.R. (2023, January 22). Osteoporosis in Females, Available online: http://www.ncbi.nlm.nih.gov/books/NBK559156/.
  5. Varacallo, M., Seaman, T.J., Jandu, J.S., and Pizzutillo, P. (2023, July 26). Osteopenia, Available online: http://www.ncbi.nlm.nih.gov/books/NBK499878/.
  6. Lowe, D., Sanvictores, T., Zubair, M., and John, S. (2023, January 22). Alkaline Phosphatase, Available online: http://www.ncbi.nlm.nih.gov/books/NBK459201/.

Cited by

See all 148

Metadata

Authors
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Kallini, Jennifer R.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2023-09-26
Volume
24
Issue
19
Pages
14583
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4387048864
Cited by
148
References
99
Citations by year
2026: 43 · 2025: 68 · 2024: 34 · 2023: 3
FWCI
8.06
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Medicinal Plant Pharmacodynamics Research
Keywords
osteoporosis, bone homeostasis, osteoimmunology, gut microbiota, cellular senescence, bone mineral density, bone turnover markers, osteoporosis diagnosis, osteoporosis treatment, fragility fractures, fracture risk
MeSH terms
Bone and Bones, Humans, Osteoporosis, Bone Density, Pathology, Molecular, Osteoporotic Fractures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics. https://app.cochat.ai/papers/10.3390/ijms241914583
The paper
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023). Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914583

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.